Dosing Flexibility Study in Patients With Rheumatoid Arthritis

NCT00580840 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

333

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Certolizumab pegol
DRUG: Certolizumab pegol
OTHER: Placebo

Sponsor

UCB Pharma